Implanet shares are soaring on the Paris Bourse this Thursday, following the orthopedic surgery specialist's announcement of a fund-raising project that seems to be reassuring the market.

The stock, which opened lower this morning, is currently up by over 46%, after having posted a gain of 87% for a time. At the same time, the CAC Small index is down by around 0.5%.

Implanet, a manufacturer of implants and medical technology equipment, has reached an agreement with the Chinese group Sanyou Medical, its reference shareholder, for the latter to participate in a capital increase of up to five million euros.

Implanet explains that it plans to launch a capital increase with preferential subscription rights (DPS) of between 5.5 and 6.4 million euros in January 2024.

This announcement comes at a time when, at the end of August, the company had only a cash position of around 300,000 euros.

In the first half of 2023, sales came to 4.27 million euros, a slight increase of 4% compared with the first half of 2022.

The company, which succeeded in controlling its operating expenses, reduced its current operating loss to 2.1 million euros in the first half, compared with -2.2 million a year earlier.

Copyright (c) 2023 CercleFinance.com. All rights reserved.